Real-world study compares dabigatran with warfarin

The risk of haemorrhage in older patients with atrial fibrillation is significantly lower with dabigatran than with warfarin, according to a real-world study from New Zealand.

Researchers from the University of Otago looked at almost 5,000 AF patients on dabigatran and a similarly sized matched cohort on warfarin.

They found an annual incidence for any haemorrhage of 5.1% with dabigatran and 11.8% with warfarin.